In the past week, NXL stock has gone down by -14.85%, with a monthly decline of -42.31% and a quarterly plunge of -55.17%. The volatility ratio for the week is 13.72%, and the volatility levels for the last 30 days are 12.08% for Nexalin Technology Inc The simple moving average for the past 20 days is -26.42% for NXL’s stock, with a -4.80% simple moving average for the past 200 days.
Is It Worth Investing in Nexalin Technology Inc (NASDAQ: NXL) Right Now?
The stock has a 36-month beta value of 4.47. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NXL is 10.77M, and at present, short sellers hold a 3.28% of that float. On March 14, 2025, the average trading volume of NXL was 371.58K shares.
NXL) stock’s latest price update
The stock of Nexalin Technology Inc (NASDAQ: NXL) has decreased by -13.33 when compared to last closing price of 2.25.Despite this, the company has seen a loss of -14.85% in its stock price over the last five trading days. globenewswire.com reported 2025-03-03 that Patent Strengthens Nexalin’s Intellectual Property Portfolio and Highlights the Potential of DIFS™ Technology in Addressing Substance Use Disorders, Including Opioids, Alcohol, Cocaine and Methamphetamine Patent Strengthens Nexalin’s Intellectual Property Portfolio and Highlights the Potential of DIFS™ Technology in Addressing Substance Use Disorders, Including Opioids, Alcohol, Cocaine and Methamphetamine
NXL Trading at -31.81% from the 50-Day Moving Average
After a stumble in the market that brought NXL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.57% of loss for the given period.
Volatility was left at 12.08%, however, over the last 30 days, the volatility rate increased by 13.72%, as shares sank -38.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -33.90% lower at present.
During the last 5 trading sessions, NXL fell by -14.85%, which changed the moving average for the period of 200-days by +83.96% in comparison to the 20-day moving average, which settled at $2.65. In addition, Nexalin Technology Inc saw -29.35% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NXL starting from Shelton Carolyn Hamby, who purchase 6,000 shares at the price of $2.20 back on Mar 12 ’25. After this action, Shelton Carolyn Hamby now owns 30,000 shares of Nexalin Technology Inc, valued at $13,200 using the latest closing price.
Owens David, the Chief Medical Officer of Nexalin Technology Inc, purchase 1,000 shares at $3.10 during a trade that took place back on Feb 04 ’25, which means that Owens David is holding 155,793 shares at $3,100 based on the most recent closing price.
Stock Fundamentals for NXL
Current profitability levels for the company are sitting at:
- -40.13 for the present operating margin
- -5.73 for the gross margin
The net margin for Nexalin Technology Inc stands at -34.27. The total capital return value is set at -1.31. Equity return is now at value -135.57, with -114.63 for asset returns.
Currently, EBITDA for the company is -5.69 million with net debt to EBITDA at 0.01. When we switch over and look at the enterprise to sales, we see a ratio of 159.56. The receivables turnover for the company is 10.68for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.39.
Conclusion
To sum up, Nexalin Technology Inc (NXL) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
